Jump to content

Cold chain: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
No edit summary
Line 17: Line 17:
The cold chain distribution process is an extension of the [[good manufacturing practice]] (GMP) environment that all drugs and biological products are required to adhere to, enforced by the various health regulatory bodies. As such, the distribution process must be validated to ensure that there is no negative impact to the safety, efficacy or quality of the drug substance. The GMP environment requires that all processes that might impact the safety, efficacy or quality of the drug substance must be evaluated, including storage and distribution of the drug substance.
The cold chain distribution process is an extension of the [[good manufacturing practice]] (GMP) environment that all drugs and biological products are required to adhere to, enforced by the various health regulatory bodies. As such, the distribution process must be validated to ensure that there is no negative impact to the safety, efficacy or quality of the drug substance. The GMP environment requires that all processes that might impact the safety, efficacy or quality of the drug substance must be evaluated, including storage and distribution of the drug substance.


It is important that one understand that the world of GMP is not some type of revolving door that one enters and exists as if it were a building.{{citation needed}} The term GMP refers to all steps in the process for making drug substances from raw materials until the administration of the drug substance to the patient. This entire process must be maintained in a state of GMP. There are those that would like to create a new standard that is not recognized by the FDA and refer to that as GDP Good Distribution Practices, but that is not an industry or governing body acceptable term.{{Weasel}}
It is important that one understand that the world of GMP is not some type of revolving door that one enters and exists as if it were a building.{{citation needed}} The term GMP refers to all steps in the process for making drug substances from raw materials until the administration of the drug substance to the patient. This entire process must be maintained in a state of GMP. There are those that would like to create a new standard that is not recognized by the FDA and refer to that as GDP Good Distribution Practices, but that is not an industry or governing body acceptable term.


==Validation==
==Validation==

Revision as of 02:09, 27 December 2009

Vaccines are temperature controlled until use
Slurry ice used to ship sensitive food products
Truck with cooling system
Iced seafood on display

A cold chain is a temperature-controlled supply chain. An unbroken cold chain is an uninterrupted series of storage and distribution activities which maintain a given temperature range. It is used help extend and ensure the shelf life of products such as fresh agricultural produce[1], processed foods, photographic film, chemicals and pharmaceutical drugs.[2]

Uses

Cold chains are common in the food and pharmaceutical industries and also some chemical shipments. One common temperature range for a cold chain in pharmaceutical industries is 2 to 8 °C. but the specific temperature (and time at temperature) tolerances depend on the actual product being shipped.

This is important in the supply of vaccines to distant clinics in hot climates served by poorly developed transport networks. Disruption of a cold chain due to war may produce consequences similar to the Smallpox outbreaks in the Philippines during the Spanish-American war.

Traditionally all historical stability data developed for vaccines was based on the temperature range of 2-8 °C. With recent development of biological products by former vaccine developers, biologics has fallen into the same category of storage at 2-8 °C due to the nature of the products and the lack of testing these products at wider storage conditions.

The cold chain distribution process is an extension of the good manufacturing practice (GMP) environment that all drugs and biological products are required to adhere to, enforced by the various health regulatory bodies. As such, the distribution process must be validated to ensure that there is no negative impact to the safety, efficacy or quality of the drug substance. The GMP environment requires that all processes that might impact the safety, efficacy or quality of the drug substance must be evaluated, including storage and distribution of the drug substance.

It is important that one understand that the world of GMP is not some type of revolving door that one enters and exists as if it were a building.[citation needed] The term GMP refers to all steps in the process for making drug substances from raw materials until the administration of the drug substance to the patient. This entire process must be maintained in a state of GMP. There are those that would like to create a new standard that is not recognized by the FDA and refer to that as GDP Good Distribution Practices, but that is not an industry or governing body acceptable term.

Validation

A cold chain can be managed by a quality management system. It should be analyzed, measured, controlled, documented, and validated.

The food industry uses the process of Hazard Analysis and Critical Control Point, HACCP, as a useful tool. Its usage continues into other fields. PDA (Parenteral Drug Association) Technical Report # 39 gives a rough summary of how the cold chain can be validated.

The overall approach to validation of a distribution process is by building more and more qualifications on top of each other to get to a validated state. This is done by executing a Component Qualification on the packaging components. Next, an Operational Qualification that demonstrates the process performs at the operational extremes. The final piece is the Performance Qualification that demonstrates that what happens in the real world is within the limits of what was demonstrated in the Operational Qualification limits.

The PDA’s Technical Report states that a Component Qualification is required to demonstrate that a component can be manufactured to the design criteria of that individual component. This was put into the document because the industry did not understand the principles of Validation; all Validation processes were specific to equipment and not auxiliary processes such as shipping/distribution.

Performing thermal testing can also help with validating the cold chain. Certified test labs use environmental chambers to simulate ambient profiles that a package may encounter in the distribution cycle. Thermocouple probes and separate temperature dataloggers measure temperatures within the product load to determine the response of the package to the test conditions. Replicate testing based on a qualification protocols is used to create a final qualification report that can be used to defend the configuration when audited by regulators. It is normally best to have an individual that understands the principles of Validation, when defending such processes to a Federal Regulatory body of any nation.

Cold chains need to be evaluated and controlled:

  • Carriers and logistics providers can assist shippers. These providers have the technical ability to link with airlines for real time status, generate web-based export documentation and provide electronic tracking.
  • The use of refrigerator trucks, refrigerator cars, reefer ships, reefer containers, and refrigerated warehouses is common.
  • Shipment in insulated shipping containers or other specialised packaging[3].
  • Temperature data loggers and RFID tags help monitor the temperature history of the truck, warehouse, etc and the temperature history of the product being shipped.[4] They also can help determine the remaining shelf life.[5]
  • Documentation is critical. Each step of the custody chain needs to follow estabilished protocols and to maintain proper records. Customs delays occur due to inaccurate or incomplete customs paperwork, so basic guidelines for creating a commercial invoice should be followed to ensure the proper verbiage, number of copies, and other details.

During the distribution process one should monitor that process until one builds a sufficient data set that clearly demonstrates the process is in compliance and in a state of control. Each time the process does not conform to the process, the event should be properly documented, investigated and corrected so that the temperature excursion do not occur on future shipments. Thus the process is continually evolving and correcting for anomalies that occur in the process. Eventually the process can evolve into periodic monitoring once sufficient data demonstrates that the process is in a state of control. Any anomaly that occurs once a process is in a state of control will result in the process being invalidated and not in control and result in product withdraw from the market to ensure patient safety.

It is necessary to develop an internal documentation system as well as multi-party communication standards and protocols to transfer or create a central repository or hub to track information across the supply chain. These systems would monitor equipment status, product temperature history, and custody chain, etc. These help ensure that a food, pharmaceutical, or vaccine is safe and effective when reaching its intended consumer.

See also

Notes

  1. ^ Kohli, Pawanexh. "Fruits and Vegetables Post-Harvest Care: The Basics" (PDF). Crosstree Techno-visors.
  2. ^ Gyesley, S. W. (1991). "Total Sysstems Approach to Predict Shelf Life of Packaged Foods". ASTM STP 1113-EB. {{cite journal}}: Cite journal requires |journal= (help); Text "issue" ignored (help)
  3. ^ Singh, S. P. (2008). "Performance comparison of thermal insulated packaging boxes, bags and refrigerants for single-parcel shipments". Packaging Technology and Science. 21 (1): 25–35. DOI: 10.1002/pts.747. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  4. ^ Riva, Marco; Piergiovanni, Schiraldi (January 2001), "Performances of time-temperature indicators in the study of temperature exposure of packaged fresh foods", Packaging Technology and Science, 14 (1): 1–39, doi:10.1002/pts.521
  5. ^ Meyers, T (2007). "RFID Shelf-life Monitoring Helps Resolve Disputes". RFID Journal. {{cite journal}}: Cite has empty unknown parameter: |1= (help); Unknown parameter |month= ignored (help)

Further reading

  • "Manual on the Management, Maintenance and Use of Blood Cold Chain Equipment", World Health Organization, 2005, ISBN 9241546735
  • Clive, D., "Cold and Chilled Storage Technology", 1997, ISBN 0751403911
  • EN 12830:1999 Temperature recorders for the transport, storage and distribution of chilled, frozen and deep-frozen/quick-frozen food and ice cream
  • Ray Cowland, Developing ISTA Cold Chain Environmental Standards, 2007.